JPWO2021241428A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021241428A5
JPWO2021241428A5 JP2022526975A JP2022526975A JPWO2021241428A5 JP WO2021241428 A5 JPWO2021241428 A5 JP WO2021241428A5 JP 2022526975 A JP2022526975 A JP 2022526975A JP 2022526975 A JP2022526975 A JP 2022526975A JP WO2021241428 A5 JPWO2021241428 A5 JP WO2021241428A5
Authority
JP
Japan
Prior art keywords
sialidase
elastin
elastin production
production promoter
promoter according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022526975A
Other languages
English (en)
Japanese (ja)
Other versions
JP7312993B2 (ja
JPWO2021241428A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/019322 external-priority patent/WO2021241428A1/ja
Publication of JPWO2021241428A1 publication Critical patent/JPWO2021241428A1/ja
Publication of JPWO2021241428A5 publication Critical patent/JPWO2021241428A5/ja
Application granted granted Critical
Publication of JP7312993B2 publication Critical patent/JP7312993B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022526975A 2020-05-25 2021-05-21 エラスチン産生促進剤及び皮膚化粧料 Active JP7312993B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020090313 2020-05-25
JP2020090313 2020-05-25
PCT/JP2021/019322 WO2021241428A1 (ja) 2020-05-25 2021-05-21 エラスチン産生促進剤及び皮膚化粧料

Publications (3)

Publication Number Publication Date
JPWO2021241428A1 JPWO2021241428A1 (https=) 2021-12-02
JPWO2021241428A5 true JPWO2021241428A5 (https=) 2023-02-02
JP7312993B2 JP7312993B2 (ja) 2023-07-24

Family

ID=78744733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022526975A Active JP7312993B2 (ja) 2020-05-25 2021-05-21 エラスチン産生促進剤及び皮膚化粧料

Country Status (5)

Country Link
US (1) US20230233437A1 (https=)
EP (1) EP4159284A4 (https=)
JP (1) JP7312993B2 (https=)
CN (1) CN115515558B (https=)
WO (1) WO2021241428A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116059309B (zh) * 2023-04-06 2023-06-30 江西中医药大学 一种精油组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07114695B2 (ja) * 1986-06-16 1995-12-13 丸金醤油株式会社 ノイラミニダ−ゼの製造法
JP2557240B2 (ja) * 1987-12-21 1996-11-27 雪印乳業株式会社 皮膚老化予防剤
GB9207280D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Skin care method and composition
DE19649096A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Glycosidasen
EP1356821B1 (en) * 1998-02-25 2007-06-20 THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response
FR2816504B1 (fr) * 2000-11-13 2003-04-18 Oreal Compositions comprenant au moins une glycosidase, lesdites compositions ne comprenant pas de protease
EP1349567A4 (en) * 2000-12-08 2005-10-12 Childrens Memorial Hospital COMPOSITIONS WITH GANGLIOSIDES FOR USE IN THE TREATMENT OF SKIN DISEASES
AU2002222436A1 (en) * 2001-12-14 2003-06-30 Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A reporter gene
US20060270707A1 (en) * 2005-05-24 2006-11-30 Zeldis Jerome B Methods and compositions using 4-[(cyclopropanecarbonylamino)methyl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione for the treatment or prevention of cutaneous lupus
JP6240447B2 (ja) 2012-12-26 2017-11-29 新田ゼラチン株式会社 エラスチン産生促進剤
JP6259207B2 (ja) 2013-06-17 2018-01-10 雪印メグミルク株式会社 エラスチン産生促進剤
WO2017015491A1 (en) * 2015-07-21 2017-01-26 Thomas Jefferson University Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathways
CN105617402A (zh) * 2016-01-15 2016-06-01 江南大学 一种唾液酸酶Neu1在制备药物方面的用途
JP6990903B2 (ja) 2016-06-09 2022-02-15 静岡県公立大学法人 シアリダーゼ阻害活性を有する化合物を含むインスリン分泌促進剤、血糖値上昇抑制剤及び糖尿病治療剤、並びにそれらの剤のスクリーニング方法

Similar Documents

Publication Publication Date Title
JP2021513520A5 (https=)
BR0007430A (pt) Composição tópica compreendendo n-acetilaminoácidos ou n-acetilaldosaminas
BR0315716A (pt) Composição e método para o tratamento dos cabelos
ATE515253T1 (de) Zusammensetzungen auf basis von etyllinoleat und triethylcitrat zur behandlung von seborrhöe und akne
AR009643A1 (es) Composiciones antimicrobianas para el cuidado personal
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
JP2010502601A5 (https=)
MX249762B (es) Acidos aldonicos de oligosacarido y su uso topico.
DE69108256D1 (de) Anwendug der saponine von medicago für die herstellung von kosmetischen oder pharmazeutischen namentlich dermatologischen zusammensetzungen welche die erneuerung der epidermis fördern,das wiederwachstum der haare stimulieren oder ihren ausfall verzögern.
BRPI9504791B8 (pt) composto de polipeptídeo e composição farmacêutica.
RU2011103256A (ru) Крем-пена для ухода за кожей
EP2983678B1 (en) Anti-microbial composition
BR0210374A (pt) Amidas de ácido antranìlico com cadeia lateral de heteroarilsulfonila, processos para produção das mesmas, uso das mesmas como medicamento ou agente de diagnóstico, bem como preparações farmacêuticas que contêm as mesmas
JPWO2021241428A5 (https=)
ES2119894T3 (es) Substancia fo-1289 y su produccion.
EP2051690A2 (en) Use of c-glycoside derivatives as pro-desquamating active agents
CA3198952A1 (en) Gel, ointment, and foam formulations of tapinarof and methods of use
WO2023143335A9 (zh) 一种诱导皮肤组织再生的亲水性静电纺植入物
ATE553760T1 (de) Verwendung von alverin zur behandlung von hauterkrankungen
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
EP4269549A3 (en) Skin cleansing compositions
Sandhu et al. Potassium iodide remains the most effective therapy for cutaneous sporotrichosis
JP2005047896A5 (https=)
ATE539749T1 (de) Dextromethorphan für die behandlung von akne
DE602004004958D1 (de) Biphasiches Mittel und dessen Verwendungen in Kosmetika